Nadav joined DeepCure in 2022 as a Senior Scientist in Assay Development and Screening. Nadav is a cellular and molecular scientist with over ten years of experience in various biological systems. Before joining DeepCure, Nadav led a research lab as a Scientific Director at the Hadassah Medical Center, where he focused on Acute Myeloid Leukemia and Leukemic stem cell in the search for novel therapeutic targets. Nadav was awarded his Ph.D. from the Weizmann Institute of Science, where he studied specialized ribosomes and translational control. He was also a postdoctoral Fellow, where he studied membrane fusion and organelle dynamics during muscle formation and regeneration.